Find More Contacts for AGTC
Protected Content
CFO
Executive Finance
1 email found 1 phone number found
View contacts for AGTC to access new leads and connect with decision-makers.
View All Contacts
  • Contact Email webmaster@agtc.com
  • Phone Number +1 386-462-2204

Applied Genetics Technologies Corporation (AGTC) is developing therapies designed to transform the lives of patients with severe diseases, offering hope to patients with unmet medical needs. With a highly specialized team of physicians and researchers, They use cutting-edge techniques to develop treatments for patients that have diseases caused by

broken genes. They use gene therapy, which replaces those broken genes with normal functional genes, allowing a patient’s own body to produce proteins to treat their illness. A single injection provides long-lasting treatment, leading to a better quality of life for patients worldwide.

Lists Featuring This Company

United States Companies With Less Than $50M in Revenue (Top 10K)
9,648 Number of Organizations • $960.4B Total Funding Amount • 91,354 Number of Investors
East Coast Companies With Less Than $500M in Revenue (Top 10K)
9,945 Number of Organizations • $771.2B Total Funding Amount • 63,234 Number of Investors
Biotechnology Acquired Companies With More Than 10 Employees
2,220 Number of Organizations • $125.9B Total Funding Amount • 5,542 Number of Investors
Florida Acquired Companies With Less Than $500M in Revenue
1,147 Number of Organizations • $13.3B Total Funding Amount • 686 Number of Investors
AGTC was acquired by Syncona Partners LLP for $23.5M on Oct 24, 2022. This deal was done in Cash.

Frequently Asked Questions

Where is AGTC's headquarters? AGTC is located in Alachua, Florida, United States.Who invested in AGTC? AGTC has 7 investors including MedImmune Ventures and Alta Partners.How much funding has AGTC raised to date? AGTC has raised .When was the last funding round for AGTC? AGTC closed its last funding round on Jul 12, 2022 from a Post-IPO Equity round.Who are AGTC's competitors? Alternatives and possible competitors to AGTC may include 4D Molecular TherapeuticsInterius BioTherapeutics, and Excision BioTherapeutics.